New Insights into the Placebo and Nocebo Responses
暂无分享,去创建一个
[1] R Ader,et al. Behaviorally Conditioned Immunosuppression , 1974, Psychosomatic medicine.
[2] M. Honda,et al. Expectation of Pain Enhances Responses to Nonpainful Somatosensory Stimulation in the Anterior Cingulate Cortex and Parietal Operculum/Posterior Insula: an Event-Related Functional Magnetic Resonance Imaging Study , 2000, The Journal of Neuroscience.
[3] G. Pagnoni,et al. Does Anticipation of Pain Affect Cortical Nociceptive Systems? , 2002, The Journal of Neuroscience.
[4] W. Chey,et al. Long-Term Safety and Efficacy of Alosetron in Women with Severe Diarrhea-Predominant Irritable Bowel Syndrome , 2004, The American Journal of Gastroenterology.
[5] D. Wendler,et al. Deception in Research on the Placebo Effect , 2005, PLoS medicine.
[6] H. Fields,et al. THE MECHANISM OF PLACEBO ANALGESIA , 1978, The Lancet.
[7] Satoshi Minoshima,et al. Gender differences in pain perception and patterns of cerebral activation during noxious heat stimulation in humans , 1998, Pain.
[8] Luana Colloca,et al. Overt versus covert treatment for pain, anxiety, and Parkinson's disease , 2004, The Lancet Neurology.
[9] D. Volc,et al. Nutzen einer Add-On-Therapie mit dem synthetischen Cannabinomimetikum Nabilone bei Patienten mit chronischen Schmerzzuständen – eine randomisierte kontrollierte Studie , 2006, Wiener klinische Wochenschrift.
[10] H. Flor,et al. Classical conditioning and expectancy in placebo hypoalgesia: A randomized controlled study in patients with atopic dermatitis and persons with healthy skin , 2007, Pain.
[11] Pierre Rainville,et al. Descending analgesia – When the spine echoes what the brain expects , 2007, PAIN.
[12] R. Sysko,et al. A systematic review of placebo response in studies of bipolar mania. , 2007, The Journal of clinical psychiatry.
[13] K. Schmidt. The Science of the Placebo – Toward an Interdisciplinary Research Agenda , 2010 .
[14] D. Sackett,et al. Methods of Blinding in Reports of Randomized Controlled Trials Assessing Pharmacologic Treatments: A Systematic Review , 2006, PLoS medicine.
[15] Raphaël Porcher,et al. Methodology for small clinical trials. , 2004, Therapie.
[16] An examination of the relationships among recalled, expected, and actual intensity and unpleasantness of delayed onset muscle pain. , 2003, The journal of pain : official journal of the American Pain Society.
[17] S. Willich,et al. The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain , 2007, PAIN.
[18] C. Büchel,et al. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network , 2006, Pain.
[19] R. Fuente-Fernández. Uncovering the hidden placebo effect in deep-brain stimulation for Parkinson's disease , 2004 .
[20] A. Hrõbjartsson,et al. Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment , 2004, Journal of internal medicine.
[21] J. Doljansky,et al. Cognitive Performance during Sustained Wakefulness: A Low Dose of Caffeine Is Equally Effective as Modafinil in Alleviating the Nocturnal Decline , 2006, Chronobiology international.
[22] V. Ramirez-Amaya,et al. Insular Cortex Lesions Impair the Acquisition of Conditioned Immunosuppression , 1996, Brain, Behavior, and Immunity.
[23] M. Schedlowski,et al. Behaviorally conditioned immunosuppression in the rat is regulated via noradrenaline and β-adrenoceptors , 2002, Journal of Neuroimmunology.
[24] Ravi S. Menon,et al. Dissociating pain from its anticipation in the human brain. , 1999, Science.
[25] M. Schulzer,et al. Placebo mechanisms and reward circuitry: clues from Parkinson's disease , 2004, Biological Psychiatry.
[26] F. Benedetti,et al. How prior experience shapes placebo analgesia , 2006, Pain.
[27] R. Ader,et al. Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. , 1982, Science.
[28] Antonia Barke,et al. The effects of experimenter characteristics on pain reports in women and men , 2004, Pain.
[29] R. Porcher,et al. Méthodologie des essais cliniques de petits effectifs , 2004 .
[30] M Schulzer,et al. Expectation and Dopamine Release: Mechanism of the Placebo Effect in Parkinson's Disease , 2001, Science.
[31] Dean Sabatinelli,et al. Affective picture perception: gender differences in visual cortex? , 2004, Neuroreport.
[32] Val Hopwood,et al. The placebo needle, is it a valid and convincing placebo for use in acupuncture trials? A randomised, single-blind, cross-over pilot trial , 2003, Pain.
[33] A. Hrõbjartsson,et al. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. , 2001, The New England journal of medicine.
[34] J M Lachin,et al. The use of response-adaptive designs in clinical trials. , 1993, Controlled clinical trials.
[35] Luana Colloca,et al. Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus , 2004, Nature Neuroscience.
[36] E. C. Ritchie,et al. Gender Differences , 1981, Language in Society.
[37] S. Austin. SUSPENDED JUDGMENT Memories of the British Streptomycin Trial in Tuberculosis The First Randomized Clinical Trial , 1990 .
[38] P. Enck,et al. Psychobiology of the placebo response , 2006, Autonomic Neuroscience.
[39] A. Bendesky,et al. On Schleppfuss' path: the placebo response in human evolution. , 2005, Medical hypotheses.
[40] F. Benedetti. Mechanisms of placebo and placebo-related effects across diseases and treatments. , 2008 .
[41] P. Duffey,et al. Conditioned immune response to interferon-γ in humans , 1999 .
[42] G. Fricchione,et al. Placebo neural systems: nitric oxide, morphine and the dopamine brain reward and motivation circuitries. , 2005, Medical science monitor : international medical journal of experimental and clinical research.
[43] Howard L Fields,et al. Isolating the Modulatory Effect of Expectation on Pain Transmission: A Functional Magnetic Resonance Imaging Study , 2006, The Journal of Neuroscience.
[44] William F Rosenberger,et al. Response‐Adaptive Randomization for Clinical Trials with Continuous Outcomes , 2006, Biometrics.
[45] A. Finset,et al. Cognitive and emotional factors in placebo analgesia. , 2006, Journal of psychosomatic research.
[46] J. R Gibbs,et al. TREATMENT OF EXCESSIVE AXILLARY SWEATING , 1974 .
[47] M. Schedlowski,et al. Conditioning in the rat: an in vivo model to investigate the molecular mechanisms and clinical implications of brain–immune communication , 2001, Immunological reviews.
[48] E. Sternberg. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens , 2006, Nature Reviews Immunology.
[49] Paul J Laurienti,et al. The subjective experience of pain: where expectations become reality. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[50] J. Zubieta,et al. Placebo effects on human μ-opioid activity during pain , 2007, Proceedings of the National Academy of Sciences.
[51] P. Petrovic,et al. Placebo and Opioid Analgesia-- Imaging a Shared Neuronal Network , 2002, Science.
[52] S. Donath,et al. Behaviorally conditioned immunosuppression using cyclosporine A: central nervous system reduces IL-2 production via splenic innervation , 1998, Journal of Neuroimmunology.
[53] A. Stoessl,et al. Understanding the Placebo Effect: Contributions from Neuroimaging , 2007, Molecular Imaging and Biology.
[54] Patrizia Baraldi,et al. Functional activity mapping of the mesial hemispheric wall during anticipation of pain , 2003, NeuroImage.
[55] P. Enck,et al. Neurophysiology and psychobiology of the placebo response , 2008, Current opinion in psychiatry.
[56] P. Enck,et al. The placebo response in functional bowel disorders: perspectives and putative mechanisms , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[57] M. Farré,et al. Placebo response in the prophylaxis of migraine: A meta‐analysis , 2008, European journal of pain.
[58] V. Ramirez-Amaya,et al. Differential Effects of NMDA-Induced Lesions into the Insular Cortex and Amygdala on the Acquisition and Evocation of Conditioned Immunosuppression , 1998, Brain, Behavior, and Immunity.
[59] F. Benedetti,et al. Potentiation of placebo analgesia by proglumide , 1995, The Lancet.
[60] F. Benedetti,et al. Autonomic and emotional responses to open and hidden stimulations of the human subthalamic region , 2004, Brain Research Bulletin.
[61] Michael Hauck,et al. Cortical correlates of false expectations during pain intensity judgments—a possible manifestation of placebo/nocebo cognitions , 2005, Brain, Behavior, and Immunity.
[62] H. Fields,et al. Analgesic responses to morphine and placebo in individuals with postoperative pain , 1981, PAIN.
[63] Thomas E. Nichols,et al. Placebo Effects Mediated by Endogenous Opioid Activity on μ-Opioid Receptors , 2005, The Journal of Neuroscience.
[64] H. Fukuyama,et al. Placebo analgesia: a PET study , 2007, Experimental Brain Research.
[65] L. Madsen,et al. Single subject trials as a research instrument in gastrointestinal pharmacology , 2002, Alimentary pharmacology & therapeutics.
[66] R. Ader. Conditioned immunomodulation: Research needs and directions , 2003, Brain, Behavior, and Immunity.
[67] F. Benedetti,et al. Opioid-Mediated Placebo Responses Boost Pain Endurance and Physical Performance: Is It Doping in Sport Competitions? , 2007, The Journal of Neuroscience.
[68] M. Farré,et al. A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials , 2006, European Journal of Clinical Pharmacology.
[69] R. Ader,et al. Conditioning of cyclophosphamide-induced leukopenia in humans. , 1996, The Journal of neuropsychiatry and clinical neurosciences.
[70] A. Nierenberg,et al. Why do clinical trials fail? The problem of measurement error in clinical trials: time to test new paradigms? , 2007, Journal of clinical psychopharmacology.
[71] L. Sandvik,et al. The effect of cimetidine in non-ulcer dyspepsia. Experience with a multi-cross-over model. , 1985, Scandinavian journal of gastroenterology.
[72] K. Perkins,et al. Acute Reinforcing Effects of Low-Dose Nicotine Nasal Spray in Humans , 1997, Pharmacology Biochemistry and Behavior.
[73] Fabrizio Benedetti,et al. Loss of expectation-related mechanisms in Alzheimer’s disease makes analgesic therapies less effective , 2006, Pain.
[74] S. Stone-Elander,et al. Anticipatory coping of pain expressed in the human anterior cingulate cortex: a positron emission tomography study , 1999, Neuroscience Letters.
[75] W. Kennedy. The nocebo reaction. , 1961, Medical world.
[76] M. Hyland,et al. Dispositional predictors of placebo responding: a motivational interpretation of flower essence and gratitude therapy. , 2007, Journal of psychosomatic research.
[77] F. Benedetti,et al. Conscious Expectation and Unconscious Conditioning in Analgesic, Motor, and Hormonal Placebo/Nocebo Responses , 2003, The Journal of Neuroscience.
[78] Robert A. Koeppe,et al. Individual Differences in Reward Responding Explain Placebo-Induced Expectations and Effects , 2007, Neuron.
[79] A. Mikami,et al. Nociceptive neurons in the macaque anterior cingulate activate during anticipation of pain , 1998, Neuroreport.
[80] C. Porro,et al. Experimental designs and brain mapping approaches for studying the placebo analgesic effect , 2008, European Journal of Applied Physiology.
[81] D. Price,et al. Revelation of a personal placebo response: Its effects on mood, attitudes and future placebo responding , 2007, PAIN.
[82] A. Zinsmeister,et al. Predictors of the placebo response in functional dyspepsia , 2006, Alimentary pharmacology & therapeutics.
[83] U. Dirnagl,et al. Central nervous system injury-induced immune deficiency syndrome , 2005, Nature Reviews Neuroscience.
[84] R. Gomeni,et al. Bayesian modelling and ROC analysis to predict placebo responders using clinical score measured in the initial weeks of treatment in depression trials. , 2007, British journal of clinical pharmacology.
[85] D. Price. Psychological and neural mechanisms of the affective dimension of pain. , 2000, Science.
[86] F. Benedetti,et al. Neuropharmacological Dissection of Placebo Analgesia: Expectation-Activated Opioid Systems versus Conditioning-Activated Specific Subsystems , 1999, The Journal of Neuroscience.
[87] S. Klosterhalfen,et al. Conditioned cyclosporine effects but not conditioned taste aversion in immunized rats. , 1990, Behavioral neuroscience.
[88] Stein Knardahl,et al. Placebo-Induced Changes in Spinal Cord Pain Processing , 2006, The Journal of Neuroscience.
[89] G. Schwartz,et al. Placebo Theory, Research , and Mechanisms , 1985 .
[90] Luana Colloca,et al. Placebos and painkillers: is mind as real as matter? , 2005, Nature Reviews Neuroscience.
[91] V. Sossi,et al. Dopamine release in human ventral striatum and expectation of reward , 2002, Behavioural Brain Research.
[92] F. Benedetti. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia , 1996, Pain.
[93] R G Hill,et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. , 1998, Science.
[94] Behaviorally Conditioned Immunosuppression , 1974 .
[95] M. Schedlowski,et al. Conditioned suppression of contact sensitivity is independent of sympathetic splenic innervation. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.
[96] Edward E. Smith,et al. Placebo-Induced Changes in fMRI in the Anticipation and Experience of Pain , 2004, Science.
[97] Fabrizio Benedetti,et al. A comprehensive review of the placebo effect: recent advances and current thought. , 2008, Annual review of psychology.
[98] U. Wiesing,et al. International Ethical Regulations on Placebo-Use in Clinical Trials: A Comparative Analysis , 2007, Bioethics.
[99] F. Benedetti,et al. Expectation enhances autonomic responses to stimulation of the human subthalamic limbic region , 2005, Brain, Behavior, and Immunity.
[100] D. Price,et al. Peripheral and central contributions to hyperalgesia in irritable bowel syndrome. , 2006, The journal of pain : official journal of the American Pain Society.
[101] U. Dirnagl,et al. CENTRAL NERVOUS SYSTEM INJURYINDUCED IMMUNE DEFICIENCY SYNDROME , 2005 .
[102] A. Leuchter,et al. Changes in brain function of depressed subjects during treatment with placebo. , 2002, The American journal of psychiatry.
[103] T. Kaptchuk,et al. The placebo effect in irritable bowel syndrome trials: a meta‐analysis 1 , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[104] H. Guess. The science of the placebo : toward an interdisciplinary research agenda , 2002 .
[105] C. Viscoli,et al. Treatment adherence and risk of death after a myocardial infarction , 1990, The Lancet.
[106] F. Benedetti,et al. When words are painful: Unraveling the mechanisms of the nocebo effect , 2007, Neuroscience.
[107] R. Sysko,et al. Placebo response in studies of major depression: variable, substantial, and growing. , 2002, JAMA.
[108] A Jon Stoessl,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Placebos and the Placebo Effect the Placebo Effect in Neurological Disorders , 2022 .
[109] K. Tracey. Physiology and immunology of the cholinergic antiinflammatory pathway. , 2007, The Journal of clinical investigation.
[110] D. Wilkin,et al. Neuron , 2001, Brain Research.
[111] W. Schimetta,et al. [Benefits of an add-on treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain--a randomized controlled trial]. , 2006, Wiener klinische Wochenschrift.
[112] A. Sclafani,et al. The Role of Gastric and Postgastric Sites in Glucose-Conditioned Flavor Preferences in Rats , 1997, Physiology & Behavior.
[113] U. Hengge,et al. Behavioral Conditioning of Antihistamine Effects in Patients with Allergic Rhinitis , 2008, Psychotherapy and Psychosomatics.
[114] A. Canbay,et al. Behavioral conditioning of immunosuppression is possible in humans , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[115] Mario Beauregard,et al. Mind does really matter: Evidence from neuroimaging studies of emotional self-regulation, psychotherapy, and placebo effect , 2007, Progress in Neurobiology.
[116] U. Mitzdorf,et al. Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials , 2007, BMC medicine.
[117] M. Mandelkern,et al. Gender differences in regional brain response to visceral pressure in IBS patients , 2000, European journal of pain.
[118] Eric R Muth,et al. Nausea induced by vection drum: contributions of body position, visual pattern, and gender. , 2008, Aviation, space, and environmental medicine.
[119] M. Cheang,et al. Defining the predictors of the placebo response in irritable bowel syndrome. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[120] Pierre Rainville,et al. Direct Comparison of Placebo Effects on Clinical and Experimental Pain , 2006, The Clinical journal of pain.
[121] R. Dolan,et al. A Functional Anatomy of Anticipatory Anxiety , 1999, NeuroImage.
[122] Peter C Gøtzsche,et al. Data extraction errors in meta-analyses that use standardized mean differences. , 2007, JAMA.
[123] H. Mcdonald,et al. Worsening of depressive symptoms prior to randomization in clinical trials: a possible screen for placebo responders? , 2004, Journal of psychiatric research.
[124] W. Schimetta,et al. 624 BENEFITS OF AN ADD‐ON TREATMENT WITH THE SYNTHETIC CANNABINOMIMETIC NABILONE ON PATIENTS WITH CHRONIC PAIN‐A RANDOMIZED CONTROLLED TRIAL , 2006 .
[125] Robert A Koeppe,et al. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. , 2008, Archives of general psychiatry.
[126] 小山 哲男. Nociceptive neurons in the macaque anterior cingulate activate during anticipation of pain , 2000 .
[127] S. Donath,et al. Conditioned immunosuppression makes subtherapeutic cyclosporin effective via splenic innervation. , 1999, The American journal of physiology.
[128] P. Duffey,et al. Conditioned immune response to interferon-gamma in humans. , 1999, Clinical Immunology.
[129] Reynold A Panettieri,et al. Placebo response in asthma: a robust and objective phenomenon. , 2007, The Journal of allergy and clinical immunology.
[130] R. A. Koelling,et al. Conditioned aversion to saccharin resulting from exposure to gamma radiation. , 1955, Science.
[131] A. Stoessl,et al. The placebo effect in Parkinson's disease , 2002, Trends in Neurosciences.
[132] C. Kirschbaum,et al. Sex-specific adaptation of endocrine and inflammatory responses to repeated nauseogenic body rotation , 2006, Psychoneuroendocrinology.
[133] J. Riley,et al. A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia , 2002, Pain.
[134] Kennedy Wp. The nocebo reaction. , 1961 .
[135] R. Rescorla,et al. Extinction of Pavlovian conditioned inhibition. , 1974, Journal of comparative and physiological psychology.
[136] K. Någren,et al. Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesia , 2005, Neuroscience Letters.
[137] W. Schultz,et al. Discrete Coding of Reward Probability and Uncertainty by Dopamine Neurons , 2003, Science.
[138] F. Benedetti. Cholecystokinin Type A and Type B Receptors and Their Modulation of Opioid Analgesia , 1997 .
[139] William L. Kelemen,et al. Expectancy and pharmacology influence the subjective effects of nicotine in a balanced-placebo design. , 2007, Experimental and clinical psychopharmacology.
[140] A. Raz. Genetics and Neuroimaging of Attention and Hypnotizability May Elucidate Placebo , 2007, The International journal of clinical and experimental hypnosis.
[141] Manfred Schedlowski,et al. Behavioural Conditioning of Immune Functions: How the Central Nervous System Controls Peripheral Immune Responses by Evoking Associative Learning Processes , 2008, Reviews in the neurosciences.
[142] B. Rostkowska-Nadolska. [Can the placebo be the cure?]. , 2007, Wiadomosci lekarskie.
[143] Michael Forsting,et al. There are differences in cerebral activation between females in distinct menstrual phases during viewing of erotic stimuli: a fMRI study , 2006, Experimental Brain Research.
[144] S. Cole-Harding,et al. Does expectancy affect alcohol absorption? , 2007, Addictive behaviors.
[145] M. Schedlowski,et al. Neural Substrates for Behaviorally Conditioned Immunosuppression in the Rat , 2005, The Journal of Neuroscience.
[146] M. Vangel,et al. Brain Activity Associated with Expectancy-Enhanced Placebo Analgesia as Measured by Functional Magnetic Resonance Imaging , 2006, The Journal of Neuroscience.
[147] H. Engler,et al. Named Series: Brain Mechanisms of Placebo Expectations and associations that heal: Immunomodulatory placebo eVects and its neurobiology , 2006 .
[148] R. de la Fuente-Fernández. Uncovering the hidden placebo effect in deep-brain stimulation for Parkinson's disease. , 2004, Parkinsonism & related disorders.
[149] L. Chang,et al. A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation , 2005, Gut.
[150] R. Hahn,et al. The nocebo phenomenon: concept, evidence, and implications for public health. , 1997, Preventive medicine.
[151] R. Lilford,et al. The Ethics of Placebo-controlled Trials: A Comparison of Inert and Active Placebo Controls , 2005, World Journal of Surgery.
[152] Anna C. Balazs,et al. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. , 1980, The New England journal of medicine.